Retroscreen Virology Limited, a global leader in anti-viral research, clinical trials and experimental challenge studies, is pleased to announce that the company will be represented at 2 key conferences during December. The first is the 7^th International Respiratory Syncytial Virus Symposium at the conference centre of the Hotel Blijdorp, Rotterdam between 2-5 December. RSV is a major cause of sever lower respiratory tract disease in infants, immunocompromised individuals and the elderly, and is a virus that Retroscreen is increasingly working with in the human challenge model. During the conference, Professor John Oxford, Chief Scientific Officer and co-founder of the company, will participate in a special event organised by Professor Albert Osterhaus.

For further information on the conference, please visit:

http://www.rsv2010.com

The second conference is the World Influenza Congress Europe which will be held at the Okura Hotel, Amsterdam between 7-9 December. This conference is an annual event which focuses specifically on vaccine development. Influenza is the fastest growing segment in the adult vaccine market and is a key research area for Retroscreen, with Professor Oxford being a recognised expert in the field. During the conference, Professor Oxford will give 2 separate presentations: the first entitled “Are we prepared for the next pandemic threat”, and the second entitled “The use of human quarantine to speed vaccine development”.

For further information on the conference, please visit:

http://terrepinn.com/2010/flu